CAS 130793-28-1
:(2S,3R,5S)-5-(2-formamido-4-methyl-pentanoyl)oxy-2-hexyl-3-hydroxy-hexadecanoic acid
Description:
The chemical substance with the name "(2S,3R,5S)-5-(2-formamido-4-methyl-pentanoyl)oxy-2-hexyl-3-hydroxy-hexadecanoic acid" and CAS number "130793-28-1" is a complex organic compound characterized by its specific stereochemistry and functional groups. It features multiple chiral centers, which contribute to its unique three-dimensional structure and potential biological activity. The presence of a formamido group indicates that it may participate in various biochemical interactions, while the hexyl and hexadecanoic acid moieties suggest hydrophobic characteristics that could influence its solubility and membrane interactions. The hydroxyl group enhances its polarity, potentially affecting its reactivity and interactions with other molecules. This compound may be of interest in pharmaceutical or biochemical research due to its structural complexity and potential applications in drug development or as a biochemical probe. Its specific properties, such as melting point, solubility, and reactivity, would require empirical investigation to fully characterize its behavior in various environments.
Formula:C29H55NO6
InChI:InChI=1/C29H55NO6/c1-5-7-9-11-12-13-14-15-16-18-24(36-29(35)26(30-22-31)20-23(3)4)21-27(32)25(28(33)34)19-17-10-8-6-2/h22-27,32H,5-21H2,1-4H3,(H,30,31)(H,33,34)/t24-,25-,26?,27+/m0/s1
InChI key:InChIKey=FKUNIADJSAJLGB-YIPNQBBMSA-N
SMILES:[C@H](C[C@H]([C@H](CCCCCC)C(O)=O)O)(OC([C@H](CC(C)C)NC=O)=O)CCCCCCCCCCC
Synonyms:- L-Leucine, N-formyl-, 1-[3-carboxy-2-hydroxynonyl]dodecyl ester, [2R-[1(S*),2R*,3S*]]-
- L-Leucine, N-formyl-, (1S)-1-[(2R,3S)-3-carboxy-2-hydroxynonyl]dodecyl ester
- N-Formyl-L-leucine (1S)-1-[(2R,3S)-3-carboxy-2-hydroxynonyl]dodecyl ester
- Orlistat Open Ring (2S,3R,5S)-Isomer
- (2S,3R,5S)-Orlistat Open Ring Impurity
- Orlistat Open Ring Epimer impurity (Orlistat Open Ring (2S,3R,5S)-Isomer)
- orlistat open ring epimer impurity
- (Orlistat IMpurity)
- (2S,3S,5S)-5-<<(S)-2-(Formylamino)-4-methylpentanoyl>oxy>-2-hexyl-3-hydroxyhexadecanoic Acid
- Orlistat Related Compound ((2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid)
- (2S, 3R, 5S)-5-[(N-ForMyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid
- Orlistat Open Ring Impurity (2S,3R,5S)-Isomer
- Orlistat open ring epimer
- (2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity)
- Orlistat Impurity 26
- N-ForMyl-L-leucine(1S)-1-[(2S,3S)-2-hydroxy-3-[(R)-1-phenylethylcarboMoyl)]
- nonyl]dodecyl-d3 Ester
- Orlistat Impurity
- nonyl]dodecyl Ester
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
Orlistat Open Ring Epimer ((2S,3R,5S)-5-((formyl-L-leucyl)oxy)-2-hexyl-3-hydroxyhexadecanoic acid)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C29H55NO6Color and Shape:Yellow SolidMolecular weight:513.40294L-Leucine, N-formyl-, (1S)-1-[(2R,3S)-3-carboxy-2-hydroxynonyl]dodecyl ester
CAS:Formula:C29H55NO6Purity:95%Color and Shape:SolidMolecular weight:513.7501Orlistat Impurity 38 (Orlistat Open Ring Epimer)
CAS:Formula:C29H55NO6Color and Shape:Off-White SolidMolecular weight:513.76(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid
CAS:Formula:C29H55NO6Purity:≥ 90%Color and Shape:White, off-white or pale yellow oil or solidMolecular weight:513.75(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity)
CAS:<p>Applications A product from thermal and hydrolytic degradation of Orlistat. Orlistat impurity.<br>References Stalder, H., et al.: Helv. Chimica Acta, 75, 1593 (1992),<br></p>Formula:C29H55NO6Color and Shape:NeatMolecular weight:513.7501(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid
CAS:Orlistat is a lipase inhibitor that is used as a weight-loss drug. It works by inhibiting the absorption of dietary fats and their subsequent conversion into triglycerides in the intestines, thereby limiting the calories absorbed. Orlistat has been shown to be effective in lymphatic and fatty acid transport, but oral bioavailability is low due to extensive first-pass metabolism. Orlistat inhibits pancreatic lipase, which may lead to reduced intestinal fat absorption and decreased systemic exposure. This drug also inhibits long-chain fatty acids from being absorbed through the intestinal wall and prevents them from being metabolized, thereby reducing lipid formulations in the blood.Formula:C29H55NO6Purity:Min. 95%Molecular weight:513.75 g/mol








